Tag
Zydus Lifesciences Limited
2 articles
Zydus Lifesciences Extends JV Investment Deadline to December 2026
Zydus Lifesciences provides regulatory update on its 50% equity investment in Zydus Sunshine Lifesciences joint venture.
Company and partner Sunshine Healthcare extend transaction completion deadline
Zydus Lifesciences Promoter Group Share Transmission
Zydus Lifesciences discloses off-market transmission of 32,577 shares from late Jasodaben Patel to Prashant Patel.
The disclosure is made under SEBI PIT Regulations regarding promoter group holdings.